insights_auto
Why is GIS up 3,58%?
Dive Deeperchevron_right
GIS:FRA
Gilead Sciences, Inc
135,56 €
arrow_upward
+3,58%(+4,68) 1D
12-окт., 15:56:42 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIS...
Open
134,80 €
High
135,56 €
Low
134,80 €
Mkt. cap
186,53 млд
Avg. vol.
386,00
Volume
1,16 миң
52-wk high
135,56 €
52-wk low
97,79 €
No. of employees
17 миң
Open
134,80 €
High
135,56 €
Low
134,80 €
Mkt. cap
186,53 млд
Avg. vol.
386,00
Volume
1,16 миң
52-wk high
135,56 €
52-wk low
97,79 €
No. of employees
17 миң
News stories
From web sources and news partners
Yahoo Finance
·
4 саат мурун
Gilead Sciences' Yeztugo Survey Supports Long-Term Growth Outlook, BofA Says
Insider Monkey
·
6 саат мурун
Can Gilead (GILD) Stock Continue Rising in 2027?
Investing.com
·
8 саат мурун
BofA raises Gilead Sciences stock price target on growth outlook
ad-hoc-news.de
·
9 саат мурун
RBC raised target for Gilead Sciences stock to USD 126.00
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About Gilead Sciences, Inc
CEODaniel O'Day
Employees17 миң
Founded1987-ж., 22-июн.
HeadquartersФостер Сити, Калифорния, Америка Кошмо Штаттары
Sector-
Websitegilead.com